<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Biochem Biophys Res Commun. 2014 May 2; 447(2): 292&#226;&#8364;&#8220;298. doi:10.1016/j.bbrc.2014.03.138. <br />  <br />  <br />  <br />                            Identification genetic interaction tumor <br />                            suppressor EAF2 retinoblastoma protein (Rb) signaling <br />                            pathway C. elegans prostate cancer cells <br />                            Liquan Cai1, Dan Wang1, Alfred L. Fisher2,3,4,5, Zhou Wang1,4,5 <br />                            1Department       Urology, The University Pittsburgh, 5200 Centre Avenue, Pittsburgh, PA 15216 <br />                            2Division <br />                                    Geriatrics, Gerontology, Palliative Medicine, Department Medicine, UTHSCSA, <br />                            San Antonio, TX 78229 <br />                            3Center    Healthy Aging, UTHSCSA, San Antonio, TX 78229 <br />                            4GRECC,       STVAHCS, San Antonio, TX 78229 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                  The tumor suppressor EAF2 regulated androgen signaling associated prostate <br />                                  cancer. While EAF2 partner ELL shown members protein complexes <br />                                  involved RNA polymerase II transcriptional elongation, biologic roles EAF2 especially <br />                                  regards development cancer remains poorly understood. We previously <br />                                  identified eaf-1 gene C. elegans ortholog EAF2, shown eaf-1 interacts <br />                                  ELL ortholog ell-1 control development fertility worms. <span id='am-4' about='protege:TO' typeof='owl:Thing'>To</span> identify genetic <br />                                  pathways interact eaf-1, screened RNAi libraries consisting transcription factors, <br />                                  phosphatases, chromatin-modifying factors identify genes enhance effects of <br />                                  eaf-1(tm3976) fertility. <span id='am-2' about='protege:FROM' typeof='owl:Thing'>From</span> screen, identified lin-53, hmg-1.2, pha-4, ruvb-2 set-6 <br />                                  hits. LIN-53 C. elegans ortholog human retinoblastoma binding protein 4/7 (RBBP <br />                                  4/7), binds retinoblastoma protein inhibits Ras signaling pathway. We find <br />                                  lin-53 showed synthetic interaction eaf-1(tm3976) knockdown lin-53 an <br />                                  eaf-1(tm3976) mutant resulted sterile worms. This <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span>phenotype</span> cell death the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  treated worms contain degenerated embryos increased expression ced-1:GFP cell <br />                                  death marker. Further interaction eaf-1 lin-53/RBBP4/7 exists in <br />                                  vertebrates, reflected formation protein complex EAF2 and <br />                                  RBBP4/7. Finally, overexpression human EAF2 RBBP4 LNCaP cells induced the <br />                                  cell death knockdown EAF2 LNCaP enhanced cell proliferation, indicating an <br />                                  important role EAF2 controlling growth <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span>survival</span> prostate cancer cells. Together <br />                                  findings identify novel physical functional interaction EAF2 Rb <br />                                  pathway. <br />  <br />  <br />  <br />                            &#194;&#169; 2014 Elsevier Inc. All rights reserved. <br />                            5 <br />                             Corresponding authors: fishera2@uthscsa.edu; FAX 210-617-5312; wangz2@upmc.edu; FAX 412-623-3907. <br />                            Publisher&apos;s Disclaimer: This PDF file unedited manuscript accepted publication. As service our <br />                            customers providing early version manuscript. The manuscript undergo copyediting, typesetting, review of <br />                            resulting proof published final citable form. Please note production process errors be <br />                            discovered affect content, legal disclaimers apply journal pertain. <br />                             Cai et al.                                                                                                       Page 2 <br />  <br />  <br />  <br />                                Keywords <br />                                         The tumor suppressor EAF2; retinoblastoma protein; lin-53; prostate cancer; RNAi library screen; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         C. elegans; apoptosis <br />  <br />  <br />                                1. Introduction <br />                                                   We previously reported identification EAF2 ortholog eaf-1 C. elegans. The <br />                                                   EAF-1 protein forms protein complex ELL ortholog ELL-1, these <br />                                                   proteins control fertility, body size, expression cuticle collagens worms [1]. <br />                                                   Despite important functions, genetic deletion eaf-1 gene worm not <br />                                                   lethal leads reduction fertility, eaf-1 mutants produce ~150 offspring <br />                                                   instead normal 300. The preserved viability fertility eaf-1 mutants could <br />                                                   indicate existence parallel pathways partially redundant eaf-1. <br />  <br />                                                   In study, used targeted RNAi screen search genetic pathways could <br />                                                   compensate loss eaf-1 preserve fertility. Via approach identified a <br />                                                   novel genetic interaction eaf-1 lin-53, worm homolog retinoblastoma <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   (Rb) binding proteins 4 7 (RBBP4/7). The Rb signaling pathway involved the <br />                                                   development ovary testis [2, 3], inhibiting formation prostate and <br />                                                   breast cancer [4, 5, 6]. Like Eaf2, loss Rb1 gives rise early stage of <br />                                                   prostate cancer mouse, loss Rb1 p53 yields significant <br />                                                   effect [7]. The tumor suppressor genes, p53, Rb1, BRCA2 [7, 8], interact <br />                                                   genetic factors control tumor progression. Hence, possible EAF2 <br />                                                   functionally and/or physically interacts Rb pathway, interaction is <br />                                                   conserved C. elegans humans plays important roles C. elegans development <br />                                                   human cancer. We validated idea testing protein-protein interactions <br />                                                   human orthologs RBBP4 EAF2. Also, discovered their <br />                                                   overlapping roles controlling cell death prostate cancer cells, implicating their <br />                                                   paralleled functions mammals. This time C. elegans used model <br />                                                   identify pathways intersect tumor suppressor gene EAF2. The <br />                                                   discovery EAF2-Rb1 genetic interaction open new avenue understanding the <br />                                                   genetic control cancer progression. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                2. Material methods <br />                                2.1. C. elegans strain, worms strains breeding <br />                                                   Wild type N2; MR142 (cdc-25.1(rr31) I; rrIs1(elt-2p:NLS-GFP); DZ325 (ezIs2 III; <br />                                                   him-8(e1489) IV, ezIs2[fkh-6::GFP + unc-119(+)]) obtained C. elegans <br />                                                   Genetics Center, supported NIH funding. ALF50 (eaf-1(tm3976)) was <br />                                                   described previously [1]. ZH231 unc-76(e911) V; enIs7 [Pced-1 ced-1::GFP + unc-76(+)] X <br />                                                   [9] generously provided Zheng Zhou (Baylor College Medicine, Houston, TX). <br />                                                   The rrIs1(elt-2p:NLS-GFP) transgene wild-type background generated by <br />                                                   outcrossing MR142 N2. <br />  <br />  <br />  <br />  <br />                                                 Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                              Page 3 <br />  <br />  <br />                                2.2. RNAi libraries individual RNAi clones <br />                                            Three RNAi libraries used study ordered Source Bioscience (Table 1). The <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            RNAi clones hmg1.2, lin-53 ruvb-1 retrieved Ahringer RNAi library <br />                                            [10]. The ell-1 RNAi clone previously described [1]. All RNAi clones validated <br />                                            DNA sequencing. <br />  <br />                                2.3. RNAi screening treatment <br />                                            The RNAi screen using library performed 12-well plates containing NGA agar <br />                                            plus 1mM IPTG 200mg/ml ampicillin. Pairs wells spotted individual <br />                                            RNAi clones fresh overnight culture grown LB media containing 200mg/ml <br />                                            ampicillin. This design resulted RNAi clone screened duplicate to <br />                                            demonstrate reproducibility screen results. Hits defined reduction F2 <br />                                            progeny numbers produced RNAi treated eaf-1 mutants compared N2. RNAi treatment <br />                                            using individual RNAi clones performed previously described [1]. Nomarski and <br />                                            fluorescent imaging performed using BX51 Olympus microscope DP70 digital <br />                                            camera. <br />  <br />                                2.4. Generation DNA constructs, Protein co-immunoprecipitation western blot <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            The RBBP4-GFP construct generated traditional DNA cloning, resulting <br />                                            plasmid DNA validated DNA sequencing. The EAF2-Myc GFP-EAF2 DNA <br />                                            constructs previously described [1]. Transfection HEK293 cells, cell lysate co- <br />                                            immunoprecipitation, PAGE electrophoresis western blotting procedures were <br />                                            previously described [1]. The antibodies used study listed follows: Anti-Myc <br />                                            tag antibody agarose (Abcam, ab1253); Anti-Myc antibody (Thermo Scientific, clone <br />                                            9E10); Anti-GFP antibody (Torrey Pines Biolabs, TP401). <br />  <br />                                2.5. Immunostaining transfected cells BrdU staining <br />                                            The LNCaP cells grown glass coverslips inserted 12-well plates. The antibody <br />                                            immunostaining carried previously described [11]. Briefly, transfected <br />                                            LNCaP cells fixed 4% paraformaldehyde 4&#194;&#176;C overnight. On day, fixed <br />                                            cells rinsed 1x PBS 0.1% Triton-100 times, followed blocking <br />                                            10% normal goat serum hour room temperature. Subsequently, first <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            antibody, secondary antibody incubation, DAPI staining applied. Photoimages <br />                                            taken Zeiss compound fluorescent microscope. The cleaved caspase-3 (Asp175) <br />                                            antibody purchased Cell Signaling (#9664) Alexa Fluor&#194;&#174; 488 Goat anti- <br />                                            Rabbit antibody Life Technologies (#A-11008). <br />  <br />                                            We used BrdU incorporation assay study effect human EAF2 gene cell <br />                                            proliferation. Briefly, LNCaP cells transfected control (Santa Cruz, sc-37007) or <br />                                            EAF2 siRNA (Santa Cruz, sc-62251) presence 1nM methyltrienolone (R1881) <br />                                            (Perkin Elmer, CAS# 965-93-5) 48h. These cells allowed incorporate 10 <br />                                            &#194;&#181;M 5-bromo-2&apos;-deoxyuridine, BrdU (Sigma, B5002) 6h. BrdU staining performed <br />                                            using standard protocol primary anti-BrdU antibody Sigma (#B-2531) a <br />  <br />  <br />  <br />  <br />                                           Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                              Page 4 <br />  <br />  <br />                                             Cy3 conjugated-goat anti-mouse secondary antibody Life technologies (A10521). <br />                                             SYTOX&#194;&#174; Green (Life technologies, S7020) used <span id='am-3' about='rdfs:label' typeof='owl:Thing'>label</span> nuclei. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                2.6. Colony formation LNCaP cells <br />                                             The colony formation assays performed previously described [12]. 1&#194;&#181;g DNA <br />                                             plasmids (GFP-EAF2, GFP-RBBP4 GFP) transfected LNCaP cells 6-well <br />                                             plate. After 24 hours, transfected cells distributed 10-cm dishes 1mg/ml <br />                                             G418 (Gemini Bio-Products, catalog# 400-111P). The culture media changed twice per <br />                                             week. After weeks, visible colonies formed (around 1 mm diameter) were <br />                                             counted GFP signals visualized using fluorescent microscope. <br />  <br />  <br />                                3. Results <br />                                3.1. RNAi library screen identification eaf-1 synthetic enhancers <br />                                             We treated eaf-1(tm3976) mutants wild type N2 worms RNAi 12- <br />                                             plates spotted clones RNAi libraries [Table 1]. Fertility was <br />                                             assessed noting number F2 progeny comparing difference N2 <br />                                             eaf-1(tm3976) mutant worms [Figure 1A]. Based criteria, identified five <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             candidate genes markedly reduced fertility eaf-1(tm3976) compared N2, <br />                                             lin-53, pha-4, hmg-1.2, ruvb-1 set-6. All genes encode nuclear <br />                                             proteins involved chromatin remodeling activation gene transcription [Table 2], <br />                                             consistent known role EAF2 transcriptional regulation. <br />  <br />                                             We chose focus lin-53 study C. elegans LIN-53 protein acts as <br />                                             worm RB complex homolog human RB binding proteins <br />                                             RBBP4/7[13]. In C. elegans, LIN-53 member Class B SynMuv protein family, <br />                                             distinct transcriptional repressor protein complexes, as <br />                                             NuRD (the nucleosome remodeling deacetylase) DRM (DP, Rb MuvB <br />                                             complex). In parallel Class A SynMuv protein family, LIN-53 regulates vulva <br />                                             formation EGFR/RAS/MAPK signaling pathway [14, 15]. Of note, these <br />                                             tumor suppressor complexes conserved humans control cancer invasiveness [16, <br />                                             17]. <br />  <br />                                             While eaf-1 <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span>mutation</span> lin-53 RNAi treatment reduced fertility worm, the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             treatment eaf-1 mutant lin-53 RNAi resulted complete sterility treated <br />                                             worms (Figure 1C). The developing embryos lin-53 RNAi treated eaf-1 mutants were <br />                                             degenerated showing largely acellular clumps instead intact embryos nicely demarked <br />                                             aligned ventral region wild-type N2 worms (Figure 1C). To lesser degree, <br />                                             single eaf-1 mutants worms treated lin-53 RNAi developed these <br />                                             degenerated embryos account reduced progeny numbers each <br />                                             individual gene inhibited (Figure 1C). <br />  <br />                                             Since C. elegans LIN-53 human RBBP4/7 change chromatin structure and <br />                                             subsequently alter gene expression [18, 19], explored inhibiting eaf-1 function <br />                                             treating worms RNAi eaf-1 partner ell-1 lin-53 RNAi change <br />                                             gene expression. To test hypothesis, used elt-2::GFP transgenic worms the <br />  <br />  <br />                                           Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                                Page 5 <br />  <br />  <br />                                            marker gene expression. This elt-2::GFP transgene exclusively expressed the <br />                                            nucleus intestinal cells, normally elt-2::GFP expression gradually vanished <br />                                            larval development (Figure 1D). Interestingly, ell-1 RNAi treatment enhanced <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            elt-2::GFP expression intestine indicating essential role ell-1 silencing of <br />                                            elt-2 expression (Figure 1D). We tested candidates identified screen <br />                                            effects elt-2::GFP expression. Surprisingly, eaf-1 genetic enhancers <br />                                            showed effects ell-1 RNAi. In particular, L4 larval RNAi treated worms retained <br />                                            highly expressed elt-2::GFP (Figure 1D E). This results support hypothesis C. <br />                                            elegans eaf-1 genetic enhancers work regulatory pathway control <br />                                            chromatin structure gene expression C. elegans intestine. <br />  <br />                                3.2. Human EAF2 RBBP4/7 physically interact human cells form nuclear <br />                                speckles <br />                                            To explore interactions tumor suppressors genes EAF2 RBBP4/7 <br />                                            occur vertebrate cells, performed co-immunoprecipitation experiment. As <br />                                            shown Figure 2, transfected EAF2 RBBP4 proteins formed complex were <br />                                            co-immunoprecipitated. We similar complex human EAF2 the <br />                                            RBBP7 protein, closely related RBBP4, transfected PC3 cells (Figure 2B). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            These findings suggest physical interactions tumor suppressors <br />                                            EAF2 RBBP4/7 human cells. <br />  <br />                                            EAF2 binding partner ELL reported regulate chromatin structure gene <br />                                            expression [20, 21]. Previously observed nuclear speckle formation cells <br />                                            overexpressing EAF2 ELL [22]. To finding, overexpressed proteins <br />                                            293 cells. Interestingly, double expression RBBP4 ELL gave rise nuclear <br />                                            speckle formation (Figure 2C), single expression RBBP4, ELL EAF2 did <br />                                            form speckles. This suggests protein-protein interaction/complex essential <br />                                            nuclear structure formation. Moreover, nuclear speckles RBBP4-ELL <br />                                            overexpression consisted bigger GFP fluorescent dots, compared the <br />                                            multiple smaller dots EAF2-ELL overexpression 293 cells (Figure 2C). The <br />                                            difference nuclear speckles implicate diverse roles proteins cell.. <br />  <br />                                3.3. EAF2 RBBP4 induce cell death prostate cancer cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Our previous studies demonstrated EAF2 acts tumor suppressor promoting <br />                                            tumor cell apoptosis [23]. We transfection RBBP4 induce cell <br />                                            death LNCaP cells (Figure 3). We performed time course study follow death of <br />                                            LNCaP cells transfected GFP-EAF2, RBBP4-GFP GFP control plasmid DNA. On <br />                                            Day 3 post transfection, great number fluorescent cells lost both <br />                                            GFP-EAF2 RBBP4-GFP transfected LNCaP cells, GFP expressing LNCaP cells <br />                                            remained relatively stable percentage total cell number (Figure 3A). Moreover, on <br />                                            Day 6 transfection, fluorescent cells GFP-EAF2 RBBP4-GFP transfection <br />                                            groups essentially lost, compared larger number fluorescent cells seen the <br />                                            GFP transfected LNCaP cells. To determine loss EAF2 RBBP4 <br />                                            expressing cells apoptosis, performed immunostaining active <br />                                            caspase-3 antibody. We anti-caspase-3 positive cells showed GFP-EAF2 <br />  <br />  <br />                                           Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                             Page 6 <br />  <br />  <br />                                          RBBP4-GFP expression contained abnormal nuclei seen DAPI staining <br />                                          (Figure 3B). We confirmed findings using western blotting caspase-3 on <br />                                          lysates LNCaP cells expressing GFP-EAF2 RBBP4-GFP 48 hours transfection <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          (Figure 3C). <br />  <br />                                          To examine eaf-1 lin-53 affect cell death C. elegans, examined the <br />                                          expression CED-1 ced-1p:ced-1:GFP transgenic worms. CED-1 transmemberane <br />                                          protein involved apoptosis pathway specifically labels dying cells [24]. lin-53 <br />                                          RNAi treatment produced increase cell death developing embryos (Figure 4A), <br />                                          indicating essential role lin-53 embryogenesis C. elegans. The <br />                                          eaf-1(tm3976) mutation produced little change CED-1:GFP expression (Figure 4A). <br />                                          However treatment eaf-1 mutants lin-53 RNAi lead prominent expression <br />                                          CED-1:GFP degenerated embryos (Figure 4A). <br />  <br />                                          We performed colony formation assay aiming investigate effects this <br />                                          functional interaction tumor cell growth. LNCaP cells transfected GFP- <br />                                          EAF2, RBBP-GFP GFP DNA plasmids subsequently treated G418 (neomycin) <br />                                          selectively grow transfected cells. After weeks, The GFP vector alone <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          transfected LNCaP cells formed colonies expressing GFP, GFP-EAF2 and <br />                                          RBBP4-GFP transfected LNCaP cells formed fewer colonies, were <br />                                          fluorescent (Figure 4B C). This reflect selective loss GFP-EAF2 or <br />                                          RBBP4-GFP genes compared neomycin resistance gene, DNA <br />                                          fragments located plasmid driven different promoters. <br />                                          Further, expression GFP-EAF2 protein lost colonies; compared the <br />                                          highly expressed GFP protein colonies derived GFP transfected LNCaP cells <br />                                          shown western blot (Figure 4D). This absence GFP-EAF2 expressing cells is <br />                                          consistent finding EAF2 functions cell death inducer [25]. To further <br />                                          characterize role EAF2, tested effect EAF2 knockdown cell proliferation in <br />                                          LNCaP model. Knockdown EAF2 siRNA increased BrdU staining positive <br />                                          LNCaP cells indicates EAF2 normally acts inhibit cell proliferation perhaps <br />                                          promoting apoptosis (Figure 4E). <br />  <br />  <br />                                4. Discussion <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          This study identified conserved interaction EAF2 RB1 occurs both <br />                                          C. elegans prostate cancer cells. Human EAF2 RB1 tumor suppressor proteins, <br />                                          RB1 gene reported frequently mutated various cancers including prostate <br />                                          cancer [26]. Meanwhile, mutant animals lacking genes show <br />                                          early stages cancer development [5, 23]. Therefore, genetic interaction between <br />                                          human EAF2 RB1 block progression later stages prostate cancer <br />                                          development. Further data clinical evidence animal models useful to <br />                                          solidify hypothesis. <br />  <br />                                          How tumor suppressors interact human cancer cells remains elusive. We <br />                                          showed protein promote cell death, consistent previous studies <br />                                          involving retinoblastoma protein [27], RBBP7 [28], EAF2 [29]. It highly possible <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                                              Page 7 <br />  <br />  <br />                                          prostate, pathways interact control cell cycle progression and/or <br />                                          cell death. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Alternatively, EAF2 RB1 alter chromatin structure gene expression. The <br />                                          nuclear speckles proposed study possible marker gene transcription <br />                                          RNA polymerase II activity. This concept supported studies involving <br />                                          ELL EAF family proteins, including Drosophila ELL [21] human EAF2 <br />                                          [20]. It important elucidate biological roles nuclear speckles, <br />                                          especially setting cancer progression. <br />  <br />  <br />                                Acknowledgments <br />                                          We grateful Dr. Shohei Mitani (National BioResource Project) providing eaf-1(tm3976) mutant. This <br />                                          research supported NIH R37 DK51193 Z. Wang ES017761 AG044768 A. Fisher well <br />                                          resources San Antonio GRECC South Texas VA Healthcare system. <br />  <br />  <br />                                References <br />                                          1. Cai L, Phong BL, Fisher AL, Wang Z. Regulation fertility, survival, cuticle collagen function <br />                                             Caenorhabditis elegans eaf-1 ell-1 genes. J Biol Chem. 2011; 286:35915&#226;&#8364;&#8220;35921. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             [PubMed: 21880729] <br />                                          2. Nalam RL, Andreu-Vieyra C, Braun RE, Akiyama H, Matzuk MM. Retinoblastoma protein plays <br />                                             multiple essential roles terminal differentiation Sertoli cells. Mol Endocrinol. 2009; <br />                                             23:1900&#226;&#8364;&#8220;1913. [PubMed: 19819985] <br />                                          3. Andreu-Vieyra C, Chen R, Matzuk MM. Conditional deletion retinoblastoma (Rb) gene in <br />                                             ovarian granulosa cells leads premature ovarian failure. Mol Endocrinol. 2008; 22:2141&#226;&#8364;&#8220;2161. <br />                                             [PubMed: 18599617] <br />                                          4. Ertel A, Dean JL, Rui H, Liu C, Witkiewicz AK, Knudsen KE, Knudsen ES. RB-pathway disruption <br />                                             breast cancer: differential association disease subtypes, disease-specific prognosis and <br />                                             therapeutic response. Cell Cycle. 2010; 9:4153&#226;&#8364;&#8220;4163. [PubMed: 20948315] <br />                                          5. Maddison LA, Sutherland BW, Barrios RJ, Greenberg NM. Conditional deletion Rb causes early <br />                                             stage prostate cancer. Cancer Res. 2004; 64:6018&#226;&#8364;&#8220;6025. [PubMed: 15342382] <br />                                          6. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock <br />                                             CE, Witkiewicz AK, Gomella L, Knudsen ES, Nelson PS, Knudsen KE. The retinoblastoma tumor <br />                                             suppressor controls androgen signaling human prostate cancer progression. J Clin Invest. 2010; <br />                                             120:4478&#226;&#8364;&#8220;4492. [PubMed: 21099110] <br />                                          7. Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, Roy-Burman P, Nikitin AY. <br />                                             Synergy p53 Rb deficiency conditional mouse model metastatic prostate cancer. <br />                                             Cancer Res. 2006; 66:7889&#226;&#8364;&#8220;7898. [PubMed: 16912162] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          8. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, <br />                                             Helleday T. Specific killing BRCA2-deficient tumours inhibitors poly(ADP-ribose) <br />                                             polymerase. Nature. 2005; 434:913&#226;&#8364;&#8220;917. [PubMed: 15829966] <br />                                          9. Venegas V, Zhou Z. Two alternative mechanisms regulate presentation apoptotic cell <br />                                             engulfment signal Caenorhabditis elegans. Mol Biol Cell. 2007; 18:3180&#226;&#8364;&#8220;3192. [PubMed: <br />                                             17567952] <br />                                          10. Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J. Effectiveness specific <br />                                               RNA-mediated interference ingested double-stranded RNA Caenorhabditis elegans. <br />                                               Genome Biol. 2001; 2 RESEARCH0002. <br />                                          11. Cai L, Brown DD. Expression type II iodothyronine deiodinase marks time tissue <br />                                               responds thyroid hormone-induced metamorphosis Xenopus laevis. Dev Biol. 2004; 266:87&#226;&#8364;&#8220; <br />                                               95. [PubMed: 14729480] <br />                                          12. Su F, Pascal LE, Xiao W, Wang Z. Tumor suppressor U19/EAF2 regulates thrombospondin-1 <br />                                               expression p53. Oncogene. 2010; 29:421&#226;&#8364;&#8220;431. [PubMed: 19826414] <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                                    Page 8 <br />  <br />  <br />                                          13. Lu X, Horvitz HR. lin-35 lin-53, genes antagonize C. elegans Ras pathway, encode <br />                                              proteins similar Rb binding protein RbAp48. Cell. 1998; 95:981&#226;&#8364;&#8220;991. [PubMed: <br />                                              9875852] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          14. Ahringer J. NuRD SIN3 histone deacetylase complexes development. Trends Genet. 2000; <br />                                              16:351&#226;&#8364;&#8220;356. [PubMed: 10904264] <br />                                          15. Solari F, Ahringer J. NURD-complex genes antagonise Ras-induced vulval development in <br />                                              Caenorhabditis elegans. Curr Biol. 2000; 10:223&#226;&#8364;&#8220;226. [PubMed: 10704416] <br />                                          16. Lai AY, Wade PA. Cancer biology NuRD: multifaceted chromatin remodelling complex. Nat <br />                                              Rev Cancer. 2011; 11:588&#226;&#8364;&#8220;596. [PubMed: 21734722] <br />                                          17. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, Liang J, Sun L, Yang X, Shi L, Li R, Li Y, <br />                                              Zhang Y, Li Q, Yi X, Shang Y. LSD1 subunit NuRD complex targets metastasis <br />                                              programs breast cancer. Cell. 2009; 138:660&#226;&#8364;&#8220;672. [PubMed: 19703393] <br />                                          18. Wang JK, Tsai MC, Poulin G, Adler AS, Chen S, Liu H, Shi Y, Chang HY. The histone <br />                                              demethylase UTX enables RB-dependent cell fate control. Genes Dev. 2010; 24:327&#226;&#8364;&#8220;332. <br />                                              [PubMed: 20123895] <br />                                          19. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W. NURD, novel complex both <br />                                              ATP-dependent chromatin-remodeling histone deacetylase activities. Mol Cell. 1998; 2:851&#226;&#8364;&#8220; <br />                                              861. [PubMed: 9885572] <br />                                          20. Kong SE, Banks CA, Shilatifard A, Conaway JW, Conaway RC. ELL-associated factors 1 2 <br />                                              positive regulators RNA polymerase II elongation factor ELL. Proc Natl Acad Sci U S A. <br />                                              2005; 102:10094&#226;&#8364;&#8220;10098. [PubMed: 16006523] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          21. Gerber M, Ma J, Dean K, Eissenberg JC, Shilatifard A. Drosophila ELL associated actively <br />                                              elongating RNA polymerase II transcriptionally active sites vivo. EMBO J. 2001; 20:6104&#226;&#8364;&#8220; <br />                                              6114. [PubMed: 11689450] <br />                                          22. Xiao W, Jiang F, Wang Z. ELL binding regulates U19/Eaf2 intracellular localization, stability, and <br />                                              transactivation. Prostate. 2006; 66:1&#226;&#8364;&#8220;12. [PubMed: 16114057] <br />                                          23. Xiao W, Zhang Q, Habermacher G, Yang X, Zhang AY, Cai X, Hahn J, Liu J, Pins M, Doglio L, <br />                                              Dhir R, Gingrich J, Wang Z. U19/Eaf2 <span id='am-239' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-240' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-245' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-248' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-258' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-259' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-267' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-268' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-287' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-291' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-293' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-295' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-308' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-309' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span>knockout</span> causes lung adenocarcinoma, B-cell lymphoma, <br />                                              hepatocellular carcinoma prostatic intraepithelial neoplasia. Oncogene. 2008; 27:1536&#226;&#8364;&#8220;1544. <br />                                              [PubMed: 17873910] <br />                                          24. Zhou Z, Hartwieg E, Horvitz HR. CED-1 transmembrane receptor mediates cell corpse <br />                                              engulfment C. elegans. Cell. 2001; 104:43&#226;&#8364;&#8220;56. [PubMed: 11163239] <br />                                          25. Xiao W, Zhang Q, Jiang F, Pins M, Kozlowski JM, Wang Z. Suppression prostate tumor growth <br />                                              U19, novel testosterone-regulated apoptosis inducer. Cancer Res. 2003; 63:4698&#226;&#8364;&#8220;4704. <br />                                              [PubMed: 12907652] <br />                                          26. Chinnam M, Goodrich DW. RB1, development, cancer. Curr Top Dev Biol. 2011; 94:129&#226;&#8364;&#8220; <br />                                              169. [PubMed: 21295686] <br />                                          27. Fung YK, T&apos;Ang A, Murphree AL, Zhang FH, Qiu WR, Wang SW, Shi XH, Lee L, Driscoll B, Wu <br />                                              KJ. The Rb gene suppresses growth normal cells. Oncogene. 1993; 8:2659&#226;&#8364;&#8220;2672. [PubMed: <br />                                              8378078] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          28. Guan LS, Li GC, Chen CC, Liu LQ, Wang ZY. Rb-associated protein 46 (RbAp46) suppresses the <br />                                              tumorigenicity adenovirus-transformed human embryonic kidney 293 cells. Int J Cancer. 2001; <br />                                              93:333&#226;&#8364;&#8220;338. [PubMed: 11433396] <br />                                          29. Hahn J, Xiao W, Jiang F, Simone F, Thirman MJ, Wang Z. Apoptosis induction growth <br />                                              suppression U19/Eaf2 mediated ELL-binding domain. Prostate. 2007; 67:146&#226;&#8364;&#8220; <br />                                              153. [PubMed: 17044034] <br />  <br />  <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                           Page 9 <br />  <br />  <br />  <br />                                                                             Highlights paper <br />                                               &#226;&#8364;&#162;    RNAi screen identified genetic enhancers C. elegans homolog EAF2. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               &#226;&#8364;&#162;    EAF2 RBBP4 proteins physically bind alter transcription. <br />  <br />                                               &#226;&#8364;&#162;    Overexpression EAF2 RBBP4 induces cell death prostate cancer <br />                                                    cells. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                                   Page 10 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 1. Synthetic interaction eaf-1 lin-53 affects C. elegans fertility gene <br />                                          expression intestine <br />                                          (A). A genetic screen using RNAi libraries (RNAis specific transcription factors, <br />                                          chromatin factors phosphatase/kinases) designed identify genetic enhancers <br />                                          working eaf-1 regulation C. elegans fertility. (B). Treatment eaf-1 <br />                                          mutant RNAi lin-53, candidates identified, resulted greater <br />                                          reduction fertility. (C). The eaf-1(tm3976);lin-53 RNAi treated worms showed extensive <br />                                          embryo degeneration seen lesser degree lin-53 RNAi treated worms. <br />  <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                           Page 11 <br />  <br />  <br />                                          The white triangle points degenerated embryos arrow points intact embryo. <br />                                          (D). The genetic enhancers identified screen share feature regulating <br />                                          expression elt2:GFP transgene intestine. The expression elt-2:GFP <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          transgene C. elegans decreases larval development strongly down-regulated <br />                                          L4 larval animals. Treatment elt-2:GFP transgenic worms ell-1 RNAi increases <br />                                          elt-2:GFP expression GFP expression observed larval stages. The <br />                                          eaf-1 enhancers (lin-53, hmg1.2, ruvb1, set-6 pha-4) observed RNAi screen have <br />                                          similar effects ell-1(RNAi) expression elt-2:GFP expression intestine. The <br />                                          white triangles panel D point intestinal cells expressing nuclear-localized GFP. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                        Page 12 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 2. Human EAF-2 RBBP4/7 form protein complex nucleus <br />                                          (A) Western blot showing co-immunoprecipitation RBBP4 EAF2 from <br />                                          transfected 293 cells. The cells transfected human EAF2-Myc RBBP4- <br />                                          GFP. The cell lysates incubated anti-Myc antibody coupled agarose after <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          washing precipitates run SDS-PAGE gel used western blotting with <br />                                          anti-GFP Myc antibodies. WCL: cell lysate. (B) Western blot showing the <br />                                          co-immunoprecipitation EAF2 RBBP7 PC3 cells. The cell lysate from <br />                                          PC3 cells transfected EAF2-Myc DNA incubated anti-Myc <br />                                          antibody linked beads, washed, used western blot anti-RBBP7 <br />                                          antibody. (C) Nuclear speckles observed human RBBP4-GFP ELL-Myc co- <br />                                          transfected 293 cells indicating RBBP4-ELL protein interaction alter chromatin <br />                                          structure. In contrast, single expression RBBP4-GFP GFP-EAF2 did rise to <br />                                          nuclear speckles. The white triangles point nuclear speckles. Note speckles <br />                                          bigger dots RBBP4-ELL overexpressed cells speckles multiple <br />                                          smaller dots EAF2-ELL overexpressed cells. <br />  <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                        Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 3. EAF2 RBBP4 induce cell death LNCaP cells <br />                                          (A). LNCaP cells transfected GFP-EAF2, RBBP4-GFP GFP vector <br />                                          plasmids GFP expressing cells visualized 1 day, 3 days 6 days after <br />                                          transfection fluorescence microscopy. GFP positive cells readily seen 6 days <br />                                          transfection GFP, transfected cells, GFP positive cells were <br />                                          progressively lost starting 3 days transfection GFP-EAF2 RBBP4-GFP <br />                                          transfected cells. (B). Immunostaining anti-active caspase-3 antibody demonstrated <br />                                          co-localization active caspase-3 GFP-EAF2 RBBP4-GFP expression, <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                     Page 14 <br />  <br />  <br />                                          indicating induction apoptosis transfected LNCaP cells 48 hours after <br />                                          transfection. Moreover, caspase-3 positive cells showed DNA condensation as <br />                                          visualized DAPI staining (Arrows point condensed nuclei). (C). Western blotting <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          anti-caspase-3 antibody demonstrated active caspase-3 protein <br />                                          expression increased LNCaP cells transfected GFP-EAF2 RBBP4-GFP after <br />                                          48 hours, compared GFP vector control transfected cells. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                             Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 4. The conserved effects cell death EAF2 RBBP4 prostate cancer cells C. <br />                                          elegans <br />                                          (A). The ced-1p:ced-1:GFP worm strain used visualize cell death. Control RNAi <br />                                          treated eaf-1(tm3976) mutant worms showed little expression CED-1:GFP. In <br />                                          contrast, lin-53 RNAi treated particularly lin-53 RNAi treated eaf-1(tm3976) mutant <br />                                          worms marked increase CED-1:GFP expression consistent increase cell <br />                                          death. The white triangles point dying embryos. (B). A colony formation assay <br />                                          performed using LNCaP cells showed GFP positive colonies GFP-EAF2 or <br />                                          RBBP4-GFP transfected LNCaP cells 3 weeks selection, GFP <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                        Page 16 <br />  <br />  <br />                                          expressing colonies observed GFP transfected LNCaP cells. (C). <br />                                          Quantification colony numbers colony formation assay. (D). The loss GFP <br />                                          expression seen western blotting using lysates colonies observed after <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          3 weeks selection. (E). Knockdown EAF2 siRNA increases LNCaP cell <br />                                          proliferation. ***, P &lt; 0.001. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                          Page 17 <br />  <br />  <br />  <br />  <br />                                                                                        Table 1 <br />  <br />                            RNAi libraries used study <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Phosphotase library (166 clones) <br />  <br />                             Transcription factors library (387 clones) <br />  <br />                             Chromatin factors library (257 clones) <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Biochem Biophys Res Commun. Author manuscript; available PMC 2015 May 02. <br />                             Cai et al.                                                                                         Page 18 <br />  <br />  <br />  <br />  <br />                                                              <br /> </body></html>